Date
|
Title
|
24.10.2012
|
EVC Aarhus, Semi-Final European Venture Contest, HealthCare, presentation, Aarhus, DK
|
20.09.2012
|
BioSpain 2012 Meeting Biotechnology, presentation, Bilbao, ES
|
04.07.2012
|
SEF-Swiss Start-Up Award,
Zurich
|
19.03.2012
|
3rd pat.pend. preceded by the 1st CH684982 patent; 2nd CH701039 (A2); PCT-WO2012-xxxxxxxxx pat.pend
|
21.11.2011
|
clinical-trials.gov; NCT00407420 (Bristol Royal Hospital,UK)/ (Dr. Per Sodersten, PhD, Karolinska Institutet, Stockholm; FDA clearance
|
17.08.2011 |
Internet presence
|
15.11.2010
|
2nd pat.pend. preceded by the 1st CH684982 patent; CH701039 (A2); PCT-WO2009-xxxxxxxxx pat.pend.
|
01.11.2010
|
Venturelab 2010 planning and training stages
|
01.11.2010
|
Venturekick &
Venturelab (Venturekick 2008 ranking 4th placeVenturelab)
|
15.06.2010
|
Prototypes; 10 fully functional products available which are in test use since June 2010
|
20.06.2010
|
Marketing and PR concept created by Partner Company, May / June 2010
|
01.01.2008
|
Erib Corp.Start and business dispositions of "Erib Corp.
|
© Copyright 2008 Erib Corp., Switzerland, All Rights
reserved - Logos, Brandnames and Models are protected by their respective
Right Holders – Impressum; AGB; Terms_&_Conditions This website contains information onproducts which is targeted to a wide range of audiences and could containproduct details or information otherwise not accessible or valid in your
country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process,regulation, registration or usage in the country of your origin.
powered by erib corp., Switzerland
- the additional web application division Update 2012
|
|